Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nutritional High International Inc. Ordinary Shares C.NHL


Primary Symbol: SPLID

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
High Fusion Inc is engaged in the manufacturing, processing, and distribution of infused edible products. The company's operating and geographical segments include Palo Verde; Pasa Verde; Oregon; Colorado; Nevada and Washington. It generates maximum revenue from the Palo Verde segment.


OTCPK:SPLID - Post by User

Nutritional High International Inc. Ordinary Shares > Annual Financials are out
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by albaflosson Nov 28, 2019 10:20pm
206 Views
Post# 30404336

RE:Annual Financials are out

RE:Annual Financials are outThey're buried in the MD&A:
For the three months and year ended July 31, 2019, the Company recognized Calyx’s revenue of approximately $5,554,180 and $23,408,630, respectively, from sales of cannabis-related products.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities